Talk:Tenofovir alafenamide

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Tenofovir alafenamide.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine
Mid	This article has been rated as Mid-importance on the project's importance scale.

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology
Mid	This article has been rated as Mid-importance on the project's importance scale.

AIDS Mid‑importance

	This article is part of WikiProject AIDS, an attempt to build a comprehensive, detailed, and accessible guide to AIDS, HIV, and related topics on Wikipedia. If you would like to participate in the project, you can choose to edit this article, or visit the project page for more information.AIDSWikipedia:WikiProject AIDSTemplate:WikiProject AIDSAIDS
Mid	This article has been rated as Mid-importance on the project's importance scale.

Controversy in TAF development

Something needs to be mentioned about TAFs controversial development stoppage by Gilead in 2004 and restart later. And the statements made around that time in 2004 being inconsistent to investors. Also there should be mention of the lawsuits from the AHF and California patients regarding TDF vs. TAF safety/development that occurred in 2016, 2017, and 2018.

Here is an LA times article that mentions some of the issues prompting the controversy. http://www.latimes.com/business/la-fi-gilead-20160529-snap-story.html — Preceding unsigned comment added by 45.26.205.106 (talk) 07:16, 3 June 2018 (UTC)[reply]